Dr. Theodore N. Fotopoulos, MD

Dr. Fotopoulos practices at New Image Dermatology in New Port Richey, Florida.

Dr. Fotopoulos' NPI, 1598765760, was assigned on July 28, 2005. Dr. Fotopoulos graduated from USF Health Morsani College of Medicine in 1990. Dr. Fotopoulos holds Florida license ME0063090.

Dr. Fotopoulos' primary practice is New Image Dermatology, at 5534 Gulf Dr Suite 1 Suite 1, New Port Richey, FL 34652-4000. The practice phone is (727) 847-3992.

Dr. Fotopoulos' primary practice is New Image Dermatology in New Port Richey, Florida. The medical group on file is New Image Dermatology.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fotopoulos practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Fotopoulos' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Fotopoulos is board certified in dermatology by the American Board of Dermatology. Dr. Fotopoulos is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and joint cyst among the conditions Dr. Fotopoulos treats.

CMS data shows 4,563 Medicare services from Dr. Fotopoulos across 24 procedure codes in 2024, for 888 Medicare patients. Medicare paid $309,107 for them. Every service was in an office.

CMS counts 888 Medicare patients who saw Dr. Fotopoulos in 2024. The largest group is 75 to 84, with 435 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fotopoulos' median patient age at 77, with 52% women.

In 2024, Dr. Fotopoulos wrote 2,135 Medicare Part D claims for 953 patients. 97% of them were for generic drugs. CMS names the drug for 2,016 of them, across 20 drugs with 11 or more claims each, at $448,003 in total drug cost. In 2023, CMS named 1,877 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Fotopoulos for performance year 2024, reported as part of a group. Dr. Fotopoulos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 120 procedures of melanoma (skin cancer) excision by Dr. Fotopoulos, more than 94% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Fotopoulos. Dr. Fotopoulos' most frequent co-authors are Jane L. Messina, MD and Philip Shenefelt, MD.

CMS Open Payments shows 23 general payments to Dr. Fotopoulos from 11 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 98% of the total. Sun Pharmaceutical Industries Inc. paid the most, $493.

Dr. Fotopoulos graduated from USF Health Morsani College of Medicine in 1990.

Dr. Fotopoulos is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.